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Abstract
Background: Water contamination with human enteric viruses has posed human health risks all over the world.
Reasonable and facile methodologies for recovering and quantifying infectious enteric viruses in environmental
samples are needed to address the issues of waterborne viral infectious diseases. In this study, a bacterial protein
that has a binding capability with several enteric viruses is discovered, and its binding characteristics were
investigated for utilizing it as a viral adsorbent in virus recovery and detection technologies.
Results: A gene of an enteric virus-binding protein (EVBP), derived from a monomer of a bacterial chaperon
protein GroEL, was successfully acquired from a genomic DNA library of activated sludge microorganisms with
nested PCR. Equilibrium dissociation constants between EVBP and norovirus-like particles (NoVLPs) of genotypes
GI.7 and GII.4, estimated with quartz crystal microbalance method, were 240 and 210 nM, respectively. These values
of equilibrium dissociation constant imply that the binding affinity between EVBP and NoVLPs is 1 to 3-log weaker
than that in general antigen-antibody interactions, but about 2-log stronger than that in weak specific interactions
of proteins with cations and organic polymers. The adsorptions of EVBP to norovirus, group A rotavirus and
poliovirus type 1 were found to be significant in enzyme-linked immunosorbent assay. Meanwhile, the binding of
native GroEL tetradecamer to viral particles was weaker than that of EVBP, presumably because of a steric
hindrance. The small molecule of EVBP could have an advantage in the access to the surface of viral particles with
rugged structure.
Conclusions: EVBP that has a broad binding spectrum to enteric viruses was newly discovered. The broad binding
characteristic of EVBP would allow us to utilize it as a novel adsorbent for detecting diverse enteric viruses in
clinical and environmental samples.
Background
Water contamination with human enteric viruses is a
growing concern, because the dissemination of human
enteric viruses in reservoir, river water and seawater
could pose human health risks for infectious viral dis-
eases via drinking water [1,2], recreation water [3], irri-
gation water [4], marine cultured products [5,6], and so
on. The quantity of infectious enteric viruses in water,
which has to be accurately determined for assessing
risks of waterborne viral diseases, is often very difficult
to analyze, because of the low concentration of enteric
viruses in water environments [7], the inability of mole-
cular detection methods to distinguish infectious and
non-infectious virions [8,9], and the presence of inhibi-
tory substances for the processes of genome extraction
and amplification [10]. Reasonable and facile methodol-
ogies for recovering and quantifying infectious enteric
viruses in environmental samples are needed to address
the issues of waterborne viral infectious diseases.
One rationalized approach to collect infectious virions
from environmental samples would be the employment
of viral antigen recovery methods by using virus-specific
antibodies [11]. The integrity of viral capsid structure,
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infectivity, and viral particles bound to specific antibo-
dies might be structurally intact. However, diverse
enteric viruses in Caliciviridae, Picornaviridae and Reo-
viridae have been recognized as waterborne agents [12],
and antibody may be too specific to capture all possible
strains of a target virus [13]. The preparation of an
array of antibodies for each enteric virus of interest
would be enormously costly and unrealistic. The discov-
ery of alternative viral adsorbents, which have a broad
binding spectrum to enteric viruses and ensure the
infectivity of recovered virions, could be very valuable
for accurately investigating health risks posed by infec-
tious enteric viruses in water environments.
Virus-binding proteins, which were discovered from a
bacterial culture derived from activated sludge [14],
could be alternative viral adsorbents, because these bac-
terial proteins can stably interact with human viral parti-
cles [15]. Recently, norovirus-binding proteins (NoVBPs)
were acquired with an affinity to a norovirus (NoV) cap-
sid peptide [16]. It was expected that these NoVBPs,
which are derived from homologues of a chaperonin
protein GroEL, had a binding capability to several NoV
genotypes, presumably because of the critical role of
hydrophobic effect [16]. This feature of a broad binding
spectrum has raised the expectation that the acquired
NoVBPs might be utilized as adsorbents for the recovery
and detection of multiple genotypes of NoV in environ-
mental samples. Furthermore, the main contribution of
hydrophobic effect might allow us to utilize these pro-
teins as adsorbents for other enteric viruses, if non-spe-
cific interactions of these proteins with impurities in
environmental samples are well excluded.
In this study, a gene of NoVBP was acquired from an
extracted genomic DNA of activated sludge microorgan-
isms, and the adsorption characteristics of the gene pro-
duct (a candidate of enteric virus-binding protein:
EVBP) to particles of enteric viruses were investigated.
Values of the equilibrium dissociation constant were
estimated with quarts crystal microbalance (QCM)
method. Furthermore, the interaction between the EVBP
candidate and enteric virus particles, including NoV
genotypes GI.7, GII.3, GII.4, GII.6, group A rotavirus
(RV-A) and poliovirus type 1 (Sabin) (PV1), was ana-
lyzed by enzyme-linked immunosorbent assay (ELISA).
Based on these binding assays, the applicability of the
gene product as EVBP was discussed.
Results
Production and purification of the EVBP candidate
A gene coding the candidate of EVBP was acquired
from the extracted genomic DNA of activated sludge
microorganisms with nested PCR [GenBank:AB618053].
The estimated molecular weight of the protein is 57
kDa. It was confirmed by BLAST search that the iso-
lated gene codes a homologue of a chaperonin GroEL
monomer. Figure 1 shows the SDS-PAGE profile of
extracted soluble proteins from E. coli cells transformed
by pDEST17/TI/EVBP and the EVBP candidate purified
with nickel ion-immobilized affinity chromatography.
Strong expression of a protein with a molecular weight
of about 60 kDa was observed in the extracted soluble
proteins from E. coli cells (Lane 1, Figure 1). This pro-
tein seemed to be histidine-tagged, because it was easily
purified by nickel ion-immobilized column (Lane 2, Fig-
ure 1). These results indicate that the production and
purification of the EVBP candidate were successfully
performed. The recovery of the target his-tag protein as
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Figure 1 Purification of the histidine-tagged EVBP candidate
with nickel column chromatography. Lane M, molecular marker;
Lane 1, extracted soluble proteins from E. coli; Lane 2, proteins
recovered in the elution step. Black arrow indicates the position of
the histidine-tagged EVBP candidate.
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Page 2 of 11a soluble protein enormously facilitates the protein pro-
cessing, because it is not necessary to purify and solubi-
lize inclusion bodies in E. coli cells.
Equilibrium dissociation constant estimated with QCM
Figure 2 shows the equilibrium adsorption isotherm of
the interaction between immobilized NoVLP (GI.7 or
GII.4) on a quartz crystal chip and the EVBP candidate,
which was analyzed by QCM. The adsorption isotherm
was acquired four times for each NoV genotype, and the
values of the equilibrium dissociation constant in the
Langmuir binding isotherm equation were estimated. As
a result, the equilibrium dissociation constants of the
EVBP candidate with NoV GI.7 and GII.4 were found
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Figure 2 Equilibrium adsorption isotherm of the interaction between immobilized NoVLP on a sensor chip and EVBP, acquired with
the quartz crystal microbalance method. The change of frequency (delta-F) was plotted against the concentration of EVBP added on a sensor
chip where NoVLP was immobilized. A, representative delta-F spots and a regression curve for NoVLP of GI.7; B, representative delta-F spots and
a regression curve for NoVLP of GII.4.
Imai et al. BMC Biotechnology 2011, 11:123
http://www.biomedcentral.com/1472-6750/11/123
Page 3 of 11out to be 240 nM (standard deviation (SD) = 60, n = 4)
and 210 nM (SD = 50, n = 4), respectively. These values
of the equilibrium dissociation constant imply that the
binding between the EVBP candidate and NoVLP is 1 to
3-log weaker than that in the specific interaction
between antibody and antigen, which can reach 0.1 nM
[17-19]. Meanwhile, the interaction between the EVBP
candidate and NoVLP is about 2-log stronger than pro-
tein adsorptions to multivalent cations and sepharose
polymers, in which the dissociation constants are
around several μM [20-22]. Our previous study showed
that bacterial proteins with a high identity in amino acid
sequence to the GroEL monomer were recovered by
their affinity to C-terminal peptide originated from NoV
GII.4 capsid, and the hydrophobic effect was likely to be
the main factor in the interaction [16]. As indicated in
Figure 3, hydrophobic amino acid residues are well con-
served among NoV genotypes in genogroups I (GI) and
II (GII). It would be plausible that the hydrophobic
region in the C-termini of NoV capsid protein, which is
exposed to outside of viral particle [23,24], is the bind-
ing site with the EVBP candidate. The gene product can
be regarded as EVBP if it exhibits this level of binding
affinity to other enteric viruses as well as to NoV.
Binding assay of the EVBP candidate with enteric virus
particles by ELISA
In order to confirm the binding capability of the EVBP
candidate to enteric viruses, ELISA using particles of
PV1, RV-A, NoV GI.7, GII3, GII.4, and GII.6 was con-
ducted. The binding assay of a native GroEL, a
tetradecamer molecule (Sigma, Japan), was also per-
formed in order to investigate the influence of the com-
plex formation on virus-binding ability. The EVBP
candidate and GroEL complex were biotinylated prior to
the binding assays, and the binding of biotinylated pro-
teins to immobilized viral particles was detected in
ELISA with avidin carrying horseradish peroxidase.
Figure 4 shows the result of ELISA, expressed in sig-
nal/noise (S/N) ratio. The S/N ratio larger than 1.0
means that the binding is significant, because this is the
ratio of absorbance at 492 nm (A492) in a virus-immobi-
lized well to that in a virus-negative (bovine serum albu-
min (BSA)-coated) well. Values of A492 in the virus-
negative well were 0.18 (SD = 0.01) and 0.73 (SD =
0.07) for the biotinylated EVBP and GroEL-inoculated
wells, respectively. The background signal caused by the
interaction of the biotinylated GroEL with the blocking
agent (BSA) was detected. Consequently, the EVBP can-
didate can bind with all virus particles tested (PV1, RV-
A, NoV GI.7, GII.3, GII.4, and GII.6), indicating that the
product of the acquired gene can be regarded as EVBP.
The hydrophobic effect could play a crucial role in the
binding of EVBP with PV1 and RV-A, because PV has
extensive hydrophobic surface on the north rim of the
canyon on the capsid surface [25], and RV has a hydro-
phobic apex on the exposed surface of the virion-distal
end (shoulder surface) of the spike body [26]. Mean-
while, the GroEL complex also gave positive S/N ratios
for all six viral particles but the values of S/N ratio were
always smaller than that of EVBP. The high background
signal caused by the adsorption of GroEL to BSA would
Accession number Genotype
NP_056821 1 482 - - - - - - L TCVPNGA SSGP QQLP INGVFVFVS WV SRF YQ LK PVGTA SSA RG RLG L R R - 530
AAA16285 3 495 - - - - - - M TCVPNSSGSGP QTLP INGVFT FVS WV SRF YQ LK PVGTA G PAR-RLG I R R S 544
CAB89090 7 491 - - - - - F I TCVPNTGGG-P QNLPTNGVFVFSSWV SRYY QLK PVGTA G PARR-LG V RRV 539
AAA92984 2 498 - - - - - - - T CVPNGV G A G P QQLPLNGVFL FVS WV SRF YQ LK PVGTA STA RG RLG V RRI 546
AAB97768 1 486 LHR QGFIT VANS- -GSRPI V VPP NGYF R F DSWV NQF YSLA PMG T G N G R R-----R V Q 535
AAB06271 3 499 LHKLG F M T VAKN - -GDSPIT VPPNGYF R F ESWV NPF YTLA PMG T G N G R R-----RI Q 548
CAA60255 4 490 LHKSGYI T VAHT- -GP YD LV LP PNGYF R F DSWV NQF YTLA PMG N G T G R R-----R A L 539
CAB89088 5 491 LHKGGFLT V SST- -STGPVVVPANGYF R F DSWV NQF YSLA PMG T G N G R R-----R F Q 540
BAC11819 6 501 LHREGFLT VANS- -GNNPI V VPP NGYF R F E A WV NQF YTLA PMG S G Q G R R-----R A Q 550
BAC11825 6 499 LHREGFIT VANS- -GNNPI V VPP NGYF R F E A WV NQF YTL T P MG T G Q G R R-----R V Q 547
BAC11831 8 489 LHKQGFIT I SNS - -GDHPI V M PANGYF R F E A WV NQF YSLA PVGTGSGRR- - - - -RI Q 537
AAF05820 8 489 LHKQGFIT I SNS - -GDHPI V M PANGYF R F E A WV KQF YSLA PVGTGSGRR- - - - -R V Q 537
BAA84716 12 487 LHRSGYI T VANT- -GSRPI V VP A NGYF R F DTWV NQF YSLA PMG T G N G R R-----R V Q 535
BAC11816 12 487 LHRSGYI T VANT- -GSRPI V VP A NGYF R F DSWV NQF YSLA PMG T G N G R R-----R V Q 535
Amino acid sequence
Figure 3 Multiple alignments of amino acid sequences from the C-terminal region of the norovirus (NoV) capsid protein. C-terminal
regions of capsid protein from human NoV genotypes GI.1 ([GenBank:NP_056821]), GI.2 ([GenBank:AAA92984]), GI.3 ([GenBank:AAA16285]), GI.7
([GenBank:CAB89090]), GII.1 ([GenBank:AAB97768]), GII.3 ([GenBank:AAB06271]), GII.4 ([GenBank:CAA60255]), GII.5 ([GenBank:CAB89088]), GII.6
([GenBank:BAC11819] and [GenBank:BAC11825]), GII.8 ([GenBank:BAC11831] and [GenBank:AAF05820]), and GII.12 ([GenBank:BAA84716] and
[GenBank:BAC11816]) were aligned by ClustalX 2.0.10 http://mac.softpedia.com/get/Math-Scientific/ClustalX.shtml. Hydrophobic residues were
indicated by grey boxes.
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A. Poliovirus 1 B. Rotavirus A
C. Norovirus GI.7  D. Norovirus GII.3
E. Norovirus GII.4 F. Norovirus GII.6
Figure 4 Binding assay of the biotinylated EVBP and the native GroEL complex with enteric virus particles. Error bars indicate the
maximum and minimum values in duplicates. A, poliovirus type 1 (Sabin); B, group A rotavirus; C, NoVLP of GI.7; D, NoVLP of GII.3; E, NoVLP of
GII.4; F, NoVLP of GII.6.
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Page 5 of 11be a hindrance when the GroEL is used as a viral
adsorbent.
Discussion
The present study investigated the applicability of EVBP
as a viral adsorbent for diverse enteric viruses in families
of Picornaviridae, Caliciviridae and Reoviridae,w h i c h
are dominant etiological agents of gastroenteritis cases
all over the world [12]. A broad binding spectrum to
human enteric viruses with a sufficient binding affinity
is an indispensable binding characteristic of EVBP for
utilizing it as a virus adsorbent. However, too low bind-
ing specificity is not preferred, because it would cause
the non-specific adsorption of impurities co-recovered
with viral particles from environmental samples, which
must hamper the interaction between EVBP and viral
particles.
A monomer of a chaperon protein GroEL was
regarded as an EVBP candidate in this study. Figure 5
shows three dimensional model of EVBP, estimated by
SWISS-MODEL, showing that hydrophobic residues are
widely distributed on its surface. Meanwhile, the native
GroEL complex, composed of 14 identical monomers
[27], is involved in the folding of denatured proteins
and de novo proteins just after translation [28]. GroEL
can interact with denatured proteins that are exposing
hydrophobic amino acid residues [29], thus having a
relatively broad spectrum of binding to thousands of
protein that have different amino acid sequences and
conformations [30]. As shown in Figure 6, hydrophobic
residues are also widely distributed on the surface of the
native GroEL complex [31]. Since the GroEL complex
can participate in the hydrophobic interactions [32], the
difference in the binding affinity observed in Figure 4
could be attributable to the configurations in each pro-
tein. The C-terminal hydrophobic region of NoV capsid
protein faces the hollows on the surface of the NoV par-
ticle [23,24], therefore, the GroEL complex could be too
large to interact with the hydrophobic region. The hol-
low on the NoV particle surface has a depth of 40 Å
and a diameter of 90 Å [33], while the GroEL complex
has a height of 142 Å and a diameter of 140 Å [34].
Since the size of canyon on the capsid surface of PV is
12Å deep and 15 Å wide [35,36], the steric hindrance
would be also significant when the GroEL complex
interacts with the hydrophobic surface of the canyon
rim of PV capsid protein. The association of the GroEL
complex with the shoulder surface of VP4 spike protein
of RV would be also difficult, because the height of the
spike is 45 Å [37], about one third of the diameter of
the GroEL complex molecule. The small molecule of
GroEL monomer (up to several nm) must have an
advantage in the access to the surface of viral particles
with rugged structure.
Although the utilization of EVBP in the detection of
enteric viruses from environmental samples was empha-
sized in this study, there are also possible applications of
EVBP in virus detection from clinical samples, especially
in the first screening for diagnostics of gastroenteritis. It
would be possible to utilize EVBP as a ligand in chro-
matography and protein microarray techniques [38].
The display on bacterial cell surface [39] and the immo-
bilization on carriers [40] could also facilitate the appli-
cation of this protein as a viral adsorbent in clinical
settings. The key aspect in the utilization of EVBP is to
curb the non-specific interactions with impurities in
clinical and environmental samples, because the hydro-
phobic effect is likely to be the main factor in the bind-
ing between viral particles and EVBP. Appropriate
blocking reagents would be required when EVBP is uti-
lized as a detection probe for enteric viruses. BSA was
employed as a blocking reagent in the ELISA, and it was
found that the binding of EVBP to BSA is negligible.
The binding spectrum of EVBP indicated in this study
could be broader than that of histo-blood group anti-
gens (HBGAs) specific to human norovirus [41], because
other enteric viruses such as enterovirus and rotavirus
are not using HBGAs as primary receptors on suscepti-
ble cells. The employment of porcine gastric mucin
including HBGAs [42] could be able to capture other
enteric viruses because of the presence of adhesive gly-
coproteins in mucin, although the non-specific adsorp-
tion of impurities also has to be overcome in the usage
of mammalian gastric mucin as a viral adsorbent. Since
pH, ionic strength and ion composition in surrounding
water are ruling the adsorption of viral particles [43], it
is important to take the measure of natural substances
with the propensity to adhere to EVBP in various condi-
tions in the further study. These efforts would offer new
techniques using this novel adsorbent for detecting
diverse enteric viruses from clinical and environmental
samples.
Conclusions
EVBP that has a broad binding spectrum to enteric
viruses was newly discovered. EVBP is derived from a
monomer of a bacterial chaperon protein GroEL, and
this small hydrophobic protein molecule of EVBP could
have an advantage in the access to the surface of viral
particles with rugged structure. The broad binding char-
acteristic of EVBP would allow us to utilize it as a novel
adsorbent for detecting diverse enteric viruses in clinical
and environmental samples.
Methods
Test virus and cells
Buffalo green monkey kidney (BGMK) cells and fetal rhe-
sus monkey kidney cells (MA-104) were cultured in
Imai et al. BMC Biotechnology 2011, 11:123
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Page 6 of 11Eagle’s minimal essential medium (MEM) with Earle’s salts
containing 10% (vol/vol) fetal bovine serum, 0.075%
NaHCO3, 2 mM L-glutamine, 10 mM nonessential amino
acids, 100 mg/ml penicillin, and 100 U/ml streptomycin.
Cells were grown to a confluent monolayer at 37°C with
5% CO2 in a humidifying incubator. PV1 and RV-A was
propagated in BGMK and MA-104 cells for 3 to 5 days at
37°C, respectively. PV1 was provided by Dr. Kazuyoshi
Yano, Tokyo Metropolitan Institute of Public Health,
Japan. RV-A was kindly supplied by Prof. Osamu
90˚
90˚
180˚
Figure 5 Tertiary structure of an enteric virus-binding protein estimated with SWISS-MODEL http://swissmodel.expasy.org/. Four lateral
faces were indicated. Hydrophobic residues (alanine, glycine, isoleucine, leucine, methionine, phenylalanine, proline and valine) were turned in
red (Tryptophan was not included in the EVBP sequence). The three dimensional structure was visualized with iMol http://www.pirx.com/iMol/.
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Page 7 of 11Nakagomi, Graduate School of Biomedical Sciences, Naga-
saki University, Japan. Virus stock was prepared by the
freeze-thaw method followed by polyethylene glycol preci-
pitation [44] and kept in 200 mL aliquots at 20°C until
use. NoVLPs of genotypes GI.7, GII.3, GII.4 and GII.6
were prepared as described elsewhere [45].
Acquisition of a gene coding a possible enteric virus-
binding protein
A genomic DNA of activated sludge microorganisms
was extracted as previously described [15]. Extracted
genomic DNA of activated sludge microorganisms was
treated with DNase-free RNase A and purified with
90˚
Figure 6 Tertiary structure of the GroEL complex [PDB:1SS8]. Two lateral faces were indicated. Hydrophobic residues (alanine, glycine,
isoleucine, leucine, methionine, phenylalanine, proline, tryptophan and valine) were turned in red. The three dimensional structure was visualized
with iMol http://www.pirx.com/iMol/.
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Page 8 of 11phenol/chloroform and 100% ethanol. The target gene
was acquired from the extracted genomic DNA of acti-
vated sludge microorganisms by nested PCR. Primers
used in this study (Table 1) were designed based on the
gene sequence of GroEL from Aeromonas sarmonicida
(accession number: CP000644.1), because it gave 100%
identity with the N-terminal amino acid sequences of
NoVBPs isolated in our previous study [16]. PCR Master
(Roche Diagnostics, Basel, Switzerland) was employed in
all steps of DNA amplification. The 1st and nested PCR
were run with 1 cycle of 95°C for 5 min, 35 cycles of
95°C for 0.5 min, 50°C for 0.5 min, and 72°C for 1 min,
and 1 cycle of 72°C for 10 min. The product size of the
1st PCR is 1823, and that of the nested PCR is 1713.
Results were visualized with gel electrophoresis using
1.0% agarose gels (stained with ethidium bromide) and
UV light. Positive PCR bands were cut from agarose
gels, and DNA was purified with GENECLEAN II KIT
(Qbiogene, France). Purified products were ligated into
pGEM-T Easy (Promega, WI, USA), which was used for
the transformation of E. coli DH5 alpha (TaKaRa, Shiga,
Japan). After cultivation at 37°C overnight, white colony
was picked up, and the vector was extracted with Mini
Prep (TaKaRa, Shiga, Japan). The sequence of the
inserted PCR product was analyzed by direct sequencing
of both strands of PCR product with ABI PRISM310
Genetic Analyzer (Applied Biosystems Japan Ltd.,
Tokyo, Japan) according to the PCR cycle sequencing
big-dye terminator protocol. Based on the determined
sequence, the tertiary structure was estimated with
SWISS-MODEL http://swissmodel.expasy.org/[46], and
visualized with iMol http://www.pirx.com/iMol/.
Construction of the cloning vector for EVBP candidate
A clone of the target gene was amplified by PCR with
primers EVBP-FW and EVBP-RV (Table 1). EVBP-FW
contains 5’-CACC-3’ region, which is used for PCR
Directional TOPO cloning (Invitrogen, CA, USA). PCR
master was used for the DNA amplification. The PCR
profile was run with 1 cycle of 95°C for 5 min, 35 cycles
of 95°C for 0.5 min, 50°C for 0.5 min, and 72°C for 1
min, and 1 cycle of 72°C for 10 min. The PCR product
size is 1634. PCR product was cloned with pENTR/SD/
D-TOPO (Invitrogen Corp., Carlsbad, CA, USA). The
cloned vector, pENTR/KW/EVBP, was used for the
transformation of E. coli cells (One Shot TOP10 Chemi-
cally Competent Cell, Invitrogen Corp., Carlsbad, CA,
USA). The target gene in pENTR/KW/EVBP was sub-
cloned into pDEST17 (Invitrogen Corp., Carlsbad, CA,
USA) with LR reaction. The pDEST17 carrying the tar-
get gene (pDEST17/TI/EVBP) was used for the transfor-
mation of E. coli DH5 alpha and purified as described
above.
Production of EVBP candidate with E. coli
Purified pDEST17/TI/EVBP was used for the transfor-
mation of E. coli BL21-AI (Invitrogen Corp., Carlsbad,
CA, USA). A preculture containing the expression plas-
mid was grown overnight at 37°C in LB medium with
ampicillin (50 mg/ml) and used to inoculate (1/50) LB
medium. The culture was grown for 4 hrs at 37°C, and
protein expression was induced by the addition of 20%
L-arabinose to a final concentration of 0.5%. After over-
night-growth at 37°C, cells were immediately collected
by centrifugation at 9,000 xg for 10 min at 4°C. The
extraction of soluble proteins was performed by BugBus-
ter (Novagen, Darmstadt, Germany). Histidine-tagged
EVBP candidate was purified with His Trap FF crude
(GE Healthcare, UK). Purified EVBP candidate was
desalted by dialysis against 20 mM NH4HCO3 (pH: 8.0)
at 4°C for at least 12 hr, and concentrated with a
vacuum and centrifugal dehydrator (CVE-100, EYELA,
TOKYO RIKAKIKAI CO. Ltd., Tokyo, Japan). EVBP
candidate in the pellet was suspended in 100 μlo fd o u -
ble-autoclaved milliQ water, and processed for SDS-
PAGE and silver staining as described previously [15].
Estimation of equilibrium dissociation constant
QCM method was employed to estimate the equilibrium
dissociation constant between the EVBP candidate and
NoVLPs. Firstly, 50 μL of NoVLP suspension of GI.7 or
GII.4 in PBS at the concentration of 10
10 particles/mL
were inoculated on the surface of a sensor chip and left
for 1 hr. NoV GII.4 is employed in the QCM test
because this genotype is the most important etiological
agent over the world [47]. NoV GI.7 is also detected in
epidemiological studies relatively frequently among NoV
GI strains [48]. The sensor chip was washed with MilliQ
water and installed in QCM machine (Single-Q0500,
BioLab). Then, 1 mg/ml of the EVBP candidate sus-
pended in PBS (pH: 6.5) was inoculated on the surface
of a sensor chip, and the frequency of chip was
recorded. The amount of the EVBP suspension inocu-
lated on the sensor chip was changed from 1 to 8 μl.
The equilibrium dissociation constant in Langmuir
Table 1 Primers used in this study
Primer Sequence (5’ -3 ’) Length Position
a Product size
EVBP-SP1-F aaccgacatcctggcgattg 20 658 1823
EVBP-SP1-R caaacccagtgcacgcatac 20 2480
EVBP-SP2-F cgaagcgtaatccacccttt 20 679 1713
EVBP-SP2-R agccgtttggtaaccaagac 20 2391
EVBP-FW caccatggcagctaaagaag 20 729
b 1634
c
EVBP-RV ttacaccatgcccatgccac 20 2358
a, position in the Aeromonas salmonicida chaperonin GroES and chaperonin
GroEL genes, complete cds (AF030975.1); b, without 5’-cacc-3’ region; c, with
5’-cacc-3’ region.
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ciated analytical software Q-UP.
Binding assay of EVBP candidate with ELISA
A5 0μl portion of virus (10
9 copies/well) or NoVLP
(10
9 particles/well) suspension was added to each well
of a microtiter and left for 1 hr to coat the well. Tripli-
cate wells were used for each sample. Then, wells were
washed twice with PBS and blocked with 5% BSA in
PBS. After incubation at room temperature for 2 hrs,
the wells were washed twice with PBS, and the biotiny-
lated EVBP candidate in 50 μl of PBS containing 5%
BSA was applied to the wells. Plates were incubated at
room temperature for 1 hr andw a s h e dt w i c ew i t hP B S
and then horseradish peroxidase (HRP)-modified strep-
tavidin (Wako, Osaka, Japan) in 50 μl of PBS containing
5% BSA was inoculated to each well. After incubation at
room temperature for 1 hr, wells were washed four
times with PBS, and HRP-modified streptavidin bound
was measured by coloring with o-phenylenediamine (P-
7288, SIGMA CHEMICAL CO., ST. Louis, MO., USA)
and H2O2 in citrate-phosphate buffer for 30 min. The
coloring reaction was stopped with 2 M H2SO4.T h e
absorbance at 492 nm (A492) was determined with a
plate reader (Multiskan MS, Labsystems, Finland).
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